You just clicked a link to go to another website. If you continue, you will leave this site and go to a site run by someone else.
Medtronic does not review or control the content on the other website, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in the Indian Subcontinent.
Any and all information provided is intended for general overview. Viewers taking any decision based on the information provided herein are requested to seek professional advice.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations.
Click “OK” to confirm you are a Healthcare Professional.
Overactive Bladder
Medtronic Bladder Control Therapy (Sacral Neuromodulation, delivered by the InterStim® System) is covered in all 50 states and Puerto Rico by Medicare, as well as by many private insurance companies.
Typically, your doctor will work with you to get prior approval from your insurance company. He or she will send a letter of medical necessity explaining why sacral neuromodulation is right for you, and confirming that more conservative treatments have been unsuccessful.
Sometimes insurance companies are unfamiliar with neurostimulation, and may turn down your initial request. Don’t be alarmed if this happens to you. Often, sending more information as part of an appeal can be helpful. Members of the Medtronic Coverage and Authorization Services Group will guide your doctor through the approval process.
Information on this site should not be used as a substitute for talking with your doctor. Always talk with your doctor about diagnosis and treatment information.